A carregar...
Drug Development for Nonalcoholic Fatty Liver Disease: Landscape and Challenges
Nonalcoholic fatty liver disease (NAFLD) is now the leading cause of chronic liver disease in industrialized economies. With no licensed treatment currently available, together with a growing prevalence that parallels global increases in obesity and type 2 diabetes, NAFLD will dominate the landscape...
Na minha lista:
| Publicado no: | J Clin Exp Hepatol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6728526/ https://ncbi.nlm.nih.gov/pubmed/31516268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2019.03.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|